Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. seras_v4.0

SERAS_v4.0 SIGNED

Seizure Risk Asessment for Epilepsy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SERAS_v4.0 project word cloud

Explore the words cloud of the SERAS_v4.0 project. It provides you a very rough idea of what is the project "SERAS_v4.0" about.

intensity    health    care    earpiece    permanent    device    monitor    algorithm    medical    everybody    discrete    invasive    patient    reports    suffers    neurological    automate    27    moved    epileptic    platform    permanently    generation    validated    mjn    suffer    social    source    create    wearable    life    global    artificial    seizure    depending    doctors    brain    predicting    environment    intelligence    people    claim    continuous    electroencephalogram    vision    knowing    2025    disruptive    plan    neuroserveis    epilepsy    65    accelerate    mobile    learning    solution    commercialization    occurs    alerts    instrument    live    suffered    ph2    monitors    seizures    pathologies    services    quality    worldwide    patients    monitoring    portable    accidents    digital    business    sme    recorded    million    turnover    functionalities    treatments    signals    predicts    serious    cloud    consists    connected    prediction    time    accident    benchmark    world    minute    market    usa    data    frequency    caused    diseases    seras    reads    containing    clinically   

Project "SERAS_v4.0" data sheet

The following table provides information about the project.

Coordinator		 MJN NEUROSERVEIS SL 

Organization address
address: AVENUE JOAN CARLES 184 PLANTA BJS PUERTA DR
city: BLANES
postcode: 17300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Total cost 2˙568˙300 €
 EC max contribution 1˙797˙810 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2021-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MJN NEUROSERVEIS SL ES (BLANES) coordinator 1˙797˙810.00

Map

 Project objective

MJN Neuroserveis’ has developed SERAS, a non-invasive, discrete and wearable device that predicts an epileptic seizure before it occurs. The device consists of an earpiece that reads the electroencephalogram, and a cloud-connected mobile application containing an artificial intelligence algorithm that alerts the user, their environment, and medical services one minute before a seizure occurs. In addition, the device permanently monitors a patient's brain activity, allowing for the generation of medical reports, the number of seizures suffered, their intensity and frequency. Currently, doctors who care for these patients do not have the data to allow for targeted patient treatments. Today, there is no device clinically validated in the market with these functionalities that can permanently monitor brain activity in a discrete, portable and continuous way. Around 50-65 million people suffers from epilepsy worldwide, depending on source. These people live in a permanent state of uncertainty, caused by not knowing when they will suffer the next seizure and if it could cause a serious accident for them. SERAS is a disruptive solution unique in monitoring brain signals and predicting epilepsy seizures with enough time to avoid accidents. MJN is a business moved by high social impact vision; our claim is ‘Quality of life for everybody’. We face a market of 6 million epileptic people in EU and USA. We aim to become a new benchmark on a global scale in the digital health world related with neurological diseases. SME Instrument Ph2 project will help us to improve our prediction algorithm in order to automate learning process and create a platform to exploit data recorded from users of the device. This will allow us and doctors go a step further on research of neurological pathologies. By Ph2 project we will accelerate our commercialization plan to scale-up our business to the goal of €27 million turnover by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SERAS_V4.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SERAS_V4.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

MIGRATECH 4.0 (2019)

The revolution in micro-granulation technology for eco-friendly, production efficient, superior ceramic tiles

Read More